Elisa Corporation/ FI0009007884 /
26/04/2024 17:29:42 | Chg. +0.16 | Volume | Bid17:29:42 | Ask17:29:42 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
42.78EUR | +0.38% | 348,056 Turnover: 13.94 mill. |
42.84Bid Size: 608 | 42.90Ask Size: 505 | 6.86 bill.EUR | 5.26% | 18.28 |
GlobeNewswire
11/03
Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitratio...
GlobeNewswire
04/03
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2...
GlobeNewswire
26/02
Nokia’s anyRAN broadens options for commercial Cloud RAN deployment and targets enterprises with par...
GlobeNewswire
22/02
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
13/02
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality...
GlobeNewswire
09/01
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clini...
GlobeNewswire
03/01
HydroGraph’s Graphene Selected by Hawkeye Bio for Use in its Early-Stage Lung Cancer Detection Biose...
GlobeNewswire
18/12/2023
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detec...
GlobeNewswire
29/11/2023
Windsor Launches New Year’s Eve Collection with Multi-Platinum artist-songwriter Megan Moroney
GlobeNewswire
16/11/2023
U.S. SMEs struggle with sustainability more than global peers, find reporting standards complex and ...
GlobeNewswire
31/10/2023
Nouscom’s Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to ‘Intercept’ Cancer in Subjects ...
GlobeNewswire
13/10/2023
Nokia and Elisa successfully complete Europe’s first Cloud RAN trial powered by In-Line acceleration